LIPO(Delisted)
Lipella·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 1
Bearish signal 2
Price Hits New Low
Price Hits 52-week Low
Bullish Abandoned Baby
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About LIPO
Lipella Pharmaceuticals Inc.
A biotech company focused on supportive care for cancer survivors with hemorrhagic cystitis
7800 Susquehanna St., Suite 505, Pittsburgh, PA 15208
--
Lipella Pharmaceuticals Inc., was incorporated in Delaware on February 16, 2005. They are a clinical-stage biotechnology company focused on developing new drugs by reformulating active agents in existing generic drugs and optimizing these reformulations for new applications.
Company Financials
EPS
LIPO has released its 2025 Q3 earnings. EPS was reported at -0.28, versus the expected 0, missing expectations. The chart below visualizes how LIPO has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
LIPO has released its 2025 Q1 earnings report, with revenue of 129.39K, reflecting a YoY change of -11.30%, and net profit of -1.31M, showing a YoY change of -9.63%. The Sankey diagram below clearly presents LIPO's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
